ENTITY
Grifols

Grifols (GRFS US)

19
Analysis
Health CareSpain
Grifols S.A. develops, manufactures, and markets plasma derivatives, IV Therapy, enteral nutrition, diagnostic systems, and medical materials.
more
bullishGrifols SA
30 Aug 2024 21:15

Brookfield Explores Sovereign Funds for Grifols Takeover Bid

Press reports Brookfield is seeking support from sovereign wealth funds, including those from Abu Dhabi (ADQ) and Singapore (GIC), to back its bid,...

Share
bullishGrifols SA
23 Aug 2024 05:45

Brookfield/Grifols: Update & Recap, Spread, Discount

Bloomberg reported that Brookfield (BN CN) is seeking bank backing for up to €9.5 billion in debt to facilitate a potential take-private...

Share
25 Jan 2024 08:55

Haier Group to Buy $1.8B Stake in Shanghai RAAS from Grifols – A New Chapter Begins

We analyzed the key points/logic behind Haier's decision to acquire Shanghai RAAS from Grifols. Despite potential risks, it is still a wise move...

Logo
492 Views
Share
x